prospective study to evaluate the safety and efficacy of resection for initially unresectable pancreatic cancer after chemo(radiation)-therapy (Prep-04 study)

prospective study to evaluate the safety and efficacy of resection for initially unresectable pancreatic cancer after chemo(radiation)-therapy (Prep-04 study) - prospective study to evaluate the safety and efficacy of resection for initially unresectable pancreatic cancer after chemo(radiation)-therapy (Prep-04 study)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017746

Enrollment

100

Registered

2015-06-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. age 20 and over 2. initially unresectable pancreatic cancer (with abutment/invasion to major artery or with distant metastasis) 3. administered non-surgical therapy for more than 3-month 4. cancer is controlled with non-surgical treatment 5. with agreement for intended surgery 6. with good general condition and torelable for surgery 7. with consent in a writing form

Exclusion criteria

Exclusion criteria: 1. age under 20 2. initially resectable 3. less than 3-month non-surgical therapy 4. progressive disease 5. not intended to resect cancer and/or without agreement 6. not tolerable for surgery 7. recurrence

Design outcomes

Primary

Measure	Time frame
resection rate	—

Secondary

Measure	Time frame
a. mortality b. morbidity c. overall survival after chemotherapy d. overall survival after surgery e. recurrence patteren	—

Countries

Japan

Contacts

Public ContactFuyuhiko MOtoi

Tohoku University Graduate School of Medicine Surgery

motoi@surg1.med.tohoku.ac.jp022-717-7205

Outcome results